Guam Regional Medical City proudly announces a groundbreaking milestone in Guam’s healthcare system with the successful ...

SAN MATEO, Calif., Aug. 25, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

Independent DSMB reports zero device-related safety issuesSupports potential clinical benefitTrial sample size re-estimated to strengthen ...

Current dogma suggests that fluid overload—when associated with acute kidney injury (AKI)—is an independent risk factor for death. Although the volume status of the patient is important, there are ...

The need for continuous renal replacement therapy may be associated with high risk of mortality among adult patients with acetaminophen-induced acute liver failure. Patients with acute liver failure ...

To provide medical professionals (RN, MD, Pharmacist) with the knowledge and understanding for decision making for the effective utilization of Continuous Renal Replacement Therapy (CRRT) and to allow ...

Researchers at the Mayo Clinic, in Rochester, Minnesota, report what they say is the first study to examine correlates of successful liberation from continuous renal replacement therapy (CRRT) in a ...

Talphera (TLPH) announced the enrollment of 17 patients in its 70-patient pivotal NEPHRO CRRT clinical trial. The enrollment of 17 patients is a milestone that was required to be achieved, and ...

SAN DIEGO--(BUSINESS WIRE)--Nikkiso America, Inc. announced it has completed the acquisition of Baxter International Inc.’s legacy Continuous Renal Replacement Therapy (CRRT) business. CRRT is a ...